TRANSPLANT BIOMEDICALS SLBeing global first reference in preservation and transport of organs and biological products with high impact revolutionary solutions
Company ceased activity. Acquisition of company assets by Cardiolink in 2020
Transplant Biomedicals develops innovative medical strategies to improve organ, tissue and cell preservation
Product description
Transplant Biomedicals is developing a new organ transport device available for hospital use. The device uses a revolutionary technology leading to superior preservation of the organs during transport from the donor hospital to the transplant center.
Our high quality and convenient product aims to become the global gold standard for transplant centers by reducing the risk of delayed graft function, improving graft survival and as such leading to better patient outcomes. In addition, our product has the potential to use part of the marginal organs that are currently discarded and thus reduce the waiting lists. [3D conceptual model]